Business · 29/10/2020Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance on Nonclinical Testing for Orally Inhaled Nicotine-Containing Drug Products
Summary
The Food and Drug Administration (FDA) has made available a final guidance document outlining the nonclinical testing requirements for orally inhaled nicotine-containing drug products, including those intended for smoking cessation and chronic indications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →